| |
| |
|
| Insider
Information: |
Hopper Jonathan Mark |
| Relationship: |
|
| City: |
Columbia |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
58,116 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,457,726 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
58,116 |
|
|
| Total
Value |
$2,457,726 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Osiris Therapeutics, Inc. |
OSIR |
|
|
0 |
|
0 |
Premium* |
|
|
Vericel Corp |
VCEL |
|
2024-05-20 |
58,116 |
2020-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCEL |
Vericel Corp |
Chief Medical Officer |
• • – |
2023-11-20 |
4 |
OE |
$10.95 |
$54,750 |
D/D |
5,000 |
58,007 |
0 |
- |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• • – |
2023-11-20 |
4 |
AS |
$36.40 |
$182,000 |
D/D |
(5,000) |
53,007 |
0 |
% |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• • – |
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,075 |
58,695 |
0 |
- |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• • – |
2024-05-20 |
4 |
OE |
$10.95 |
$109,500 |
D/D |
10,000 |
68,116 |
0 |
- |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• • – |
2024-05-20 |
4 |
AS |
$49.99 |
$499,900 |
D/D |
(10,000) |
58,116 |
0 |
% |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2021-12-22 |
4 |
AS |
$40.08 |
$596,930 |
D/D |
(14,881) |
43,547 |
0 |
% |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2022-03-01 |
4 |
AS |
$41.41 |
$693,431 |
D/D |
(16,738) |
49,176 |
0 |
% |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2021-03-30 |
4 |
AS |
$50.56 |
$921,270 |
D/D |
(17,924) |
38,480 |
0 |
% |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2021-12-22 |
4 |
OE |
$10.95 |
$265,150 |
D/D |
19,000 |
49,428 |
0 |
- |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2022-03-01 |
4 |
OE |
$10.95 |
$289,500 |
D/D |
20,000 |
55,914 |
0 |
- |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2020-12-21 |
4 |
AS |
$26.27 |
$643,159 |
D/D |
(24,235) |
23,360 |
0 |
% |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2021-03-30 |
4 |
OE |
$10.95 |
$366,146 |
D/D |
33,438 |
49,584 |
0 |
- |
|
| VCEL |
Vericel Corp |
Chief Medical Officer |
• – – |
2020-12-21 |
4 |
OE |
$10.95 |
$473,741 |
D/D |
43,264 |
35,069 |
0 |
- |
|
38 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
